AI assistant
Sending…
Vir Biotechnology, Inc. — Director's Dealing 2023
Feb 22, 2023
32538_dirs_2023-02-21_8516b64e-3585-43d7-9213-333212c94c70.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2023-02-17
Reporting Person: Pang Phillip (Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-17 | Common Stock | S | 2802 | $25.288 | Disposed | 141198 | Direct |
Footnotes
F1: Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
More from Vir Biotechnology, Inc.
Regulatory Filings
2026
May 28
Proxy Solicitation & Information Statement
2026
Apr 16
Regulatory Filings
2026
Apr 10
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2
Regulatory Filings
2026
Feb 26